HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: AJPH.2007.129924v1 98/8/1468    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kabir, Z. Articles by Capewell, S. Search for Related Content PubMed PubMed Citation Articles by Kabir, Z. Articles by Capewell, S. Related Collections Health Policy Health Promotion Public Health Practice Tobacco Control Cardiovascular Disease

Zubair Kabir, MD, PhD, Gregory N. Connolly, DMD, MPH, Luke Clancy, MD, FRCPI, Howard K. Koh, MD, MPH and Simon Capewell, MD, MFPH

At the time of the study, Zubair Kabir was a research fellow at the Harvard School of Public Health, Boston, MA. Gregory N. Connolly and Howard K. Koh are with the Division of Public Health Practice, Harvard School of Public Health, Boston. Luke Clancy is with the Research Institute for a Tobacco Free Society, Dublin, Ireland. Simon Capewell is with the Division of Public Health, University of Liverpool, England.

Correspondence: Requests for reprints should be sent to Zubair Kabir, MD, PhD, Research Institute for a Tobacco Free Society, The Digital Depot, Thomas Street, Dublin 8, Ireland (email: zkabir{at}hsph.harvard.edu; zkabir{at}tri.ie)

We used the previously validated IMPACT coronary heart disease (CHD) mortality model to estimate the CHD deaths attributable to reductions in smoking prevalence following the introduction of the Massachusetts Tobacco Control Program (MTCP) in 1993. A 29% and 31% decline in smoking prevalence and CHD mortality rates occurred, respectively (from 1993 to 2003). A total of 425 fewer CHD deaths, which generated approximately 3365 extra life-years, were attributable to decreased smoking prevalence. With these results in mind, a comprehensive tobacco control program should be sustained and supported.